Business context and reporting period
Mettler-Toledo International Inc. filed this Form 10-K for the fiscal year ended December 31, 2012. The company supplies precision instruments and related services, including laboratory and industrial weighing equipment, analytical and process instruments, product inspection systems, and food-retail weighing solutions. Its five reportable segments are U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The filing also provides unaudited fourth-quarter results.
Financial performance and liquidity
| Metric | 2012 | 2011 |
|---|---|---|
| Net sales | $2,341.5 million | $2,309.3 million |
| Gross profit / gross margin | $1,241.1 million / 53.0% | $1,218.3 million / 52.8% |
| Earnings before taxes | $382.6 million | $349.2 million |
| Net earnings | $290.8 million | $269.5 million |
| Diluted earnings per share | $9.14 | $8.21 |
| Cash from operating activities | $327.7 million | $280.9 million |
| Capital expenditures | $95.6 million | $98.5 million |
| Cash and cash equivalents at year-end | $101.7 million | $235.6 million |
| Total debt at year-end | $388.7 million | $505.0 million |
- Revenue grew 1% in U.S. dollars and 4% in local currencies. Product sales increased 1% in U.S. dollars; service revenue, including spare parts, increased 1%.
- Product gross margin was 56.2%, compared with 56.3%; service gross margin improved to 40.9% from 39.4%. Management attributed the overall gross-margin improvement to pricing, lower material costs, and favorable currency translation, partly offset by geographic mix and field-service investment.
- The 2012 effective tax rate was 24%, versus 23% in 2011. The filing reports no operating-margin figure in the supplied text.
- Operating cash flow less capital expenditures was approximately $232.1 million in 2012, calculated from the reported figures. Cash declined by $133.9 million during the year, principally amid financing activity that included $278.7 million of share repurchases.
- Year-end net debt was approximately $287.0 million, calculated as total debt less cash. Working capital, as defined by the company excluding cash and specified debt, was $242.1 million, up from $201.7 million.
- The $880 million revolving credit facility had $197.1 million drawn and approximately $677.9 million available at year-end. The company reported compliance with its debt covenants.
Fourth-quarter results
Fourth-quarter sales were $657.3 million, compared with $648.4 million in 2011; net earnings were $104.6 million versus $94.3 million; diluted EPS was $3.35 versus $2.91.
Material changes versus the prior comparable period
- Growth slowed sharply from 2011, when sales rose 17% in U.S. dollars and 13% in local currencies. Europe sales declined 8% in U.S. dollars (2% in local currencies) in 2012, while Americas and Asia/Rest of World sales increased 4% and 11%, respectively, in U.S. dollars.
- Laboratory-related sales rose 2% in U.S. dollars and 5% in local currencies, below 2011 local-currency growth of 9%. Industrial-related sales rose 2% and 4%, respectively, versus 19% local-currency growth in 2011. Food-retailing sales fell 7% in U.S. dollars and 4% in local currencies.
- Net earnings increased about 8%, while diluted EPS increased about 11%, supported in part by a lower weighted-average share count following repurchases.
- Restructuring charges rose to $16.7 million from $5.9 million, primarily for severance and other cost-reduction measures initiated in response to economic conditions.
- Segment results were mixed: U.S. segment profit increased 14% and Swiss segment profit increased 17%; Western European segment profit declined 4%, Chinese segment profit increased 4%, and Other segment profit declined 2%.
Outlook, management commentary, risks, and contingencies
- Management expects 2013 local-currency organic sales growth to be below 2011 rates; sales could decline in future quarters depending on economic conditions. It expects slower growth in laboratory-related products, especially in Europe, and industrial products, especially in Europe and China; food-retailing sales may also continue to decline. No specific numerical 2013 earnings or sales guidance is provided in the filing text.
- Management cited weaker European conditions, slower Chinese growth, reduced university and government research spending in developed markets, and volatility in food-retail project activity. It expects continued support from market leadership, product breadth, emerging-market investment, and sales and marketing initiatives.
- Key exposures include global economic weakness and customer capital-spending delays; competition and pricing pressure; international and China-specific operating, currency, and cash-repatriation risks; Swiss-franc and euro movements; supply interruptions; and execution, cost, and disruption risks associated with the multiyear Blue Ocean ERP and process-standardization program. Blue Ocean capital spending exceeded $20 million annually, including $47.9 million in 2012.
- The company reported $16.7 million of 2012 restructuring expense and an $11.9 million restructuring accrual at year-end. Its annual impairment review found no impairment of goodwill or indefinite-lived intangible assets.
- Environmental matters include groundwater monitoring and remediation at a New Jersey site, with estimated compliance costs of approximately $0.5 million over the next several years; the company also disclosed that a natural-resource-damages claim had been informally anticipated but not filed. Management did not expect existing legal proceedings to materially affect results, financial condition, or cash flows, but acknowledged potential future environmental liabilities.
- Defined-benefit plans were underfunded, including a reported $129.7 million combined funded-status deficit for U.S. and non-U.S. pension plans, excluding the separate $11.3 million post-retirement obligation. The company expected 2013 employer contributions of approximately $26.6 million across pension and post-retirement plans.
- The company repurchased $278.7 million of stock in 2012; $437 million remained authorized under its $2.25 billion program. Management stated that operating cash flows and available credit were expected to fund anticipated working-capital and capital-spending needs for the foreseeable future.
Important facts for investors to verify
- Whether 2013 demand and local-currency growth—particularly in Europe and China—track management’s cautious outlook, and whether food-retail declines persist.
- How pricing, product mix, service investment, and cost-reduction actions affect margins as sales growth slows; also monitor the additional restructuring program and its costs.
- Whether operating cash flow remains sufficient alongside capital spending, pension funding, and continued share repurchases, given the year-over-year decline in cash.
- Debt levels, credit-facility availability, covenant compliance, and sensitivity to foreign-exchange movements, especially the Swiss franc and euro.
- Execution and costs of Blue Ocean implementation, including the planned U.S. and German rollouts, and any resulting operational or financial-reporting disruption.
- Developments in tax examinations and the New Jersey environmental matter, including any natural-resource-damages claim or other newly identified remediation liabilities.